Cited by 375Malaria Research and ControlTravel-related health issuesPhytochemical compounds biological activities

Effectiveness of Antimalarial Drugs

Baird, J. Kevin·2005·New England Journal of Medicine

Abstract

A global resurgence of malaria has taken place as a result of a lapse in preventive efforts and the emergence of resistance to standard antimalarial drugs. New therapies are available, but because of social, economic, and clinical factors, the use of older drugs persists. This review considers current approaches to the prevention and treatment of malaria.

Integrity signals

Registry

Crossref · 10.1056/nejmra043207

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Killing parasites in RBCs requires prolonged treatment with high doses, which results in toxicities, potential for missed doses and development of resistance.

    “Killing parasites in the RBCs requires prolonged treatment with high doses, which results in toxicities, potential for missed doses and development of resistance 104 .”

    From Nanotechnology approaches for global infectious diseases (2021) · cites this paper as [104]

The citation lists haven’t been fetched yet

References 117 · Cited by 375

Authors
Baird, J. K.
Corresponding author
Baird, J. Kevin
Venue
New England Journal of Medicine
Published
2005-04-14
Volume
352
Issue
15
Pages
1565-1577
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2169812632
Cited by
375
References
117
Citations by year
2025: 7 · 2024: 7 · 2023: 7 · 2022: 11 · 2021: 8 · 2020: 11 · 2019: 13 · 2018: 9 · 2017: 7 · 2016: 15 · 2015: 18 · 2014: 26 · 2013: 19 · 2012: 27
FWCI
5.32
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Lincoln (University of Nebraska) (submittedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Travel-related health issues
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phytochemical compounds biological activities
Keywords
malaria, antimalarial drugs, drug resistance, malaria prevention, malaria treatment
MeSH terms
Animals, Antimalarials, Chloroquine, Drug Combinations, Drug Resistance, Drug Therapy, Combination, Humans, Life Cycle Stages, Malaria, Patient Compliance, Plasmodium, Primaquine, Pyrimethamine, Quinine, Sulfadoxine, Mefloquine, Treatment Failure, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review